To investigate this, we used the online platform ROC Plotter [46], which integrates multiple transcriptome-level gene expression datasets available through GEO into a single database containing information for 3104 breast cancer patients linked to corresponding response data for a range of treatments, including endocrine therapies, anti-HER2 therapies and chemotherapeutic drugs [27]. Here, ERBB2 is linked to breast carcinoma.